Harris Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Harris Associates's ELV Position: Q3 2026 in Review
Harris Associates reduced its Elevance Health (ELV) stake by 3% in Q3 2026, selling an estimated $58.2M and leaving 4,778,654 shares worth $1.86B. The position accounts for 2.42% of the portfolio, ranked #9.
Harris Associates first reported a position in ELV in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.9B in Q2 2026. 1,627 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Harris Associates held 4,778,654 shares of Elevance Health worth $1.86B as of Q3 2026.
- Harris Associates sold 145,857 Elevance Health shares in Q3 2026, an estimated $58.2M.
- Elevance Health made up 2.42% of Harris Associates's portfolio in Q3 2026, its #9 holding.
- Harris Associates first reported a position in Elevance Health in Q4 2024 and has held it in 8 quarters since.
- Harris Associates's Elevance Health position peaked at $1.9B in Q2 2026.
- 1,627 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Harris Associates's 13F filing for Q3 2026, filed 16 Nov 2026.